NCT01553201View on ClinicalTrials.gov

Botulinum Toxin for Pelvic Pain in Women With Endometriosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 30, 2014

Primary Completion Date

July 31, 2018

Study Completion Date

July 24, 2019

Conditions
EndometriosisChronic Pelvic PainPelvic Muscle SpasmQuality of Life
Interventions
DRUG

Botulinum toxin (BoNT)

OnabotulinumtoxinA 100 Units diluted in 4cc saline, one time intramuscular administration

DRUG

Placebo

Saline, 4cc, one time intramuscular administration

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT01553201 - Botulinum Toxin for Pelvic Pain in Women With Endometriosis | Biotech Hunter | Biotech Hunter